Seven companies were chosen from a pool of 69 applicants to further develop their online, mobile and software solutions to healthcare problems. Each will receive up to $50,000, professional mentorship, and introductions to a variety of key healthcare stakeholders including insurers, pharmaceutical companies, hospitals and research institutions located in the Greater Philadelphia region, with the goal of getting their products into the hands of potential customers.
The inaugural DHA class includes the following startups:
Biomeme, a DreamIt Ventures 2013 graduate, uses their technology to transform a smartphone into a mobile lab for advanced DNA diagnostics and real-time disease surveillance, identifying targets by their specific molecular signatures.
Curbside Care is the “Uber for healthcare,” coordinating on-demand house calls via mobile and web-based applications. Their platform bridges a market of fragmented supply and untapped demand by connecting off-shift MDs and NPs to patient users in real time.
Fitly, another 2013 DreamIt Ventures graduate, is a mobile app that helps busy people personalize healthy meals from delicious recipes in five minutes or less, and then delivers the fresh ingredients to their home for as little as $5.99/serving.
Keosys, based in France, is an established European leader in medical imaging software solutions, helping physicians efficiently deliver the most accurate diagnosis in radiology, nuclear medicine and molecular imaging practices.
Life Patch is a small, non-invasive, real-time temperature monitoring system that allows parents to track their child’s temperature from anywhere in the world using any smart device.
Pulse Infoframe, a Canadian firm, enables specialty physicians, administrators, pharmaceutical companies and researchers to collaborate to continuously improve quality and cost of patient care through a software platform called HealthIE and a powerful Realtime Clinical Business Intelligence toolset.
UE Lifesciences offers innovative, affordable and easy-to-use medical devices for breast cancer screening.
The DHA is supported in part by funding from the Commonwealth of Pennsylvania’s Discovered and Developed in PA (D2PA) program.
Source: Jeanne Mell, University City Science Center
Writer: Elise Vider